文献速递肿瘤 PET/CT放射性药物与辐射防护

68Ga-PSMA PET/CT中模拟转移瘤的肝脏灌注相关假病灶

Hepatic Perfusion-Related Pseudolesion Mimicking Metastasis on 68 Ga-PSMA PET/CT.
PubMed 文献 · Clin Nucl Med · 2026-05-05

本文报道一例前列腺癌患者,68Ga-PSMA PET/CT显示肝VIII段楔形PSMA摄取增高。MRI未见局灶性病变,仅见轻度弥散高信号不伴ADC减低及一过性动脉期高强化,符合灌注相关假病灶而非转移瘤。

要点

  • 68Ga-PSMA PET/CT肝内楔形摄取增高需警惕灌注假病灶
  • MRI弥散高信号不伴ADC减低及一过性动脉期强化支持良性灌注改变
  • 避免将肝脏灌注相关假病灶误判为前列腺癌肝转移

核心结论

  • 肝脏楔形PSMA摄取增高可为灌注相关假病灶,而非转移瘤。

研究设计与样本

  • 本文为单例病例报告,报道一例前列腺癌患者的影像学发现。

主要发现

  • 68Ga-PSMA PET/CT显示肝VIII段楔形PSMA摄取增高。
  • MRI未见局灶性病变,但见轻度弥散高信号不伴ADC减低及一过性动脉期高强化。
  • 上述表现符合灌注相关假病灶而非转移性疾病。

临床怎么用

  • 对PSMA PET/CT肝内楔形摄取增高病例,应结合MRI弥散及增强序列鉴别灌注假病灶。

局限性

  • 本文为单例病例报告,结论的普遍适用性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PSMA is a critical cell-surface molecule and 68 Ga-PSMA PET has become an established imaging modality that improves disease localization for newly diagnosed and recurrent prostate cancer. We report a patient with wedge-shaped increased PSMA uptake in segment VIII of the liver. MRI demonstrated no focal lesion; however, mild diffusion hyperintensity without apparent diffusion coefficient reduction and transient arterial hyperenhancement were observed. These findings were consistent with a perfusion-related pseudolesion rather than metastatic disease.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Oksuzoglu K, Perktas L, Onner H, et al. Hepatic Perfusion-Related Pseudolesion Mimicking Metastasis on 68 Ga-PSMA PET/CT. Clin Nucl Med. 2026. PMID: 42148830. doi:10.1097/RLU.0000000000006520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。